Introduction
Acute radiation injury to the intestines may occur during radiotherapy and is characterized by diarrhoea and tenesmus. Symptoms were relieved by treatment with cholestyramine.
Case report
A 72-year-old woman was treated with radiotherapy for carcinoma of the bladder. She was given a course of telecobalt therapy, 30 fractions in 45 days. The total tumour dose was 6000 rad.
During the 4th week of radiotherapy her stools became watery and loose and by the 5th week she was having 18-20 watery stools/day. Treatment with kaolin and morphine, 10 ml/6 hr, 2 tablets/6 hr of diphenoxylate and atropine (Lomotil), and dihydrocodeine 60 mg/4 hr reduced the number of stools to 9-10/day but faecal consistency was unchanged.
All treatment was stopped for 24 hr and a 3-day collection of faeces was made. The patient was given cholestyramine 4 g/6 hr and 4 g at night. Over the next 24 hr she had ten semi-solid stools and the following day there were four fairly well formed stools. Thereafter two to three formed stools/day were passed and a second 3-day collection of faeces was made.
Total faecal bile acids were normal at 311 mg/ 24 hr -lithocholic acid was 103-105 mg and deoxycholic was 207-5 mg. No measurable quantities of chenodeoxycholic and cholic acids were found in the stools.
The number of motions and faecal biochemistry before and during cholestyramine therapy are compared in Table 1 . Because of a poor appetite, the patient had a small food intake as reflected by low dry weight of faeces. It is, therefore, possible that if the bile acids were expressed in terms of dry weight of faeces, their concentration in the gut lumen might be higher than that in a normal person, and thus account for the diarrhoea and its response to cholestyramine.
Patients with diarrhoea as a result of radiotherapy for pelvic malignancy have abnormal bowel radiology and positive cholyl-glycine-1-14C breath tests (Newman et al., 1973) . Based on the conversion of glycine-1-14C to CO2 by bacterial and tissue enzymes, the test is positive in bacterial overgrowth syndromes and when the entero-hepatic circulation is interrupted by ileal damage or disease (Hofmann et al., 1970; James et al., 1972; Condon et al., 1974) .
It should, however, be noted that, unlike patients with ileal resections (Mitchell and Eastwood, 1972) , no measurable quantities of chenodeoxycholic and cholic acids were found in the faeces of the patient and this suggests bacterial activity of organisms known to break down primary to secondary bile acids. Since dilatation of the ileum and failure of the terminal ileal loop to retain barium has been reported, it is conceivable that post-radiation diarrhoea might be related to bacterial invasion of the ileum as a consequence of radiation damage to the ileo-caecal valve. The normal total faecal bile acids of the patient would tend to support this concept rather than malabsorption by the terminal ileum, in which case one would expect stool bile acids to be unequivocally elevated.
One must, however, account for the dramatic response to cholestyramine and it is known that the compound may affect bacterial activity in a number of ways. Firstly, the resin is capable of binding endotoxin (Nolan and Ali, 1972) , and there is evidence that endotoxins can cause diarrhoea Gorbach, 1970; Gorbach and Khurana, 1972) . Furthermore, the bacterial flora of the gut might also be modified by cholestyramine. The reasons for this are twofold. Certain organisms such as Bacteroides fragilis are stimulated by bile acids and the activity of such bacteria may be decreased by the unavailability of bile acids bound to the resin. Secondly, certain bile acids exert a pronounced bactericidal effect at pH 5-6 and this decreases as the pH rises to 7-2 (Percy-Robb and Collee, 1972) .
The authors have controlled radiation diarrhoea in two other patients and the resin has been reported as preventing symptoms in some animals with radiation-induced enteritis (Berk and Seay, 1972) . The compound may, therefore, be a useful drug for controlling this debilitating disorder in man. 
